Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_assertion type Assertion NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_head.
- NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_assertion description "[Pharmaceutical agents such as valproate, which counteract the effects of genetically determined reduced clusterin expression, may help to achieve neuroprotection and contribute to the prevention of dementia, especially in carriers of these CLU risk variants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_provenance.
- NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_assertion evidence source_evidence_literature NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_provenance.
- NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_assertion SIO_000772 24806679 NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_provenance.
- NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_assertion wasDerivedFrom befree-2016 NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_provenance.
- NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_assertion wasGeneratedBy ECO_0000203 NP1180379.RAccJVNZtpOUxmBL7MzDm4FqfWdAkAXikagStRgZcSq8E130_provenance.